# SGI earnings call intelligence

LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/SGI) · [Earnings tab](https://www.lopjlb.com/stock/SGI?tab=earnings)

Updated: 2026-11-09T04:58:11

Quarters analyzed: 8

## Cross-quarter narrative

Across eight quarterly call summaries SGI’s story shifts from early margin strength and tentative guidance to a pronounced focus on integration, international expansion and capital deployment. The 2024‑23 quarters spotlighted solid margins and a nascent Sealy launch, while the 2024 Q4 merger completion set the stage for synergy capture. 2025 Q1 saw guidance trimmed amid weak consumer confidence, but by Q2 the Mattress Firm integration was ahead of plan, delivering a $40 million EBITDA boost and prompting an EPS upgrade. Record sales and EBITDA in Q3‑Q4 2025 were driven by strong synergies, a disciplined store‑refresh program and aggressive advertising, even as the U.S. bedding market softened. International growth accelerated, culminating in multiple acquisitions reported in 2026 Q2. Pricing actions and cost‑saving initiatives offset commodity inflation, supporting margin improvement. The Leggett & Platt combination emerged as a new strategic pillar in 2026, though its completion remains at risk. Throughout, recurring concerns around U.S. demand softness, UK competitive pressure and integration execution persist, while newer worries about macro volatility, tariff exposure and ERP rollout appear later.

## Latest CallCard · Q2

SomniGroup posted a record Q2 adjusted EPS of $0.58 on $1.8B sales, highlighted strong Mattress Firm performance, Kingsdown expansion, ongoing store refreshes, pricing actions offsetting inflation, and a near‑final Leggett & Platt deal.

**Guidance:** maintained — Full‑year adjusted EPS guidance of $2.85‑$3.15 and gross margin guidance slightly above 45% were reaffirmed.

**Tone:** mgmt 0.6 · Q&A pressure 0.5 · divergence 0.4

Prepared remarks emphasized record earnings, brand strength and progress on initiatives, conveying optimism.

### Demand visibility

Demand remains steady with strong Mattress Firm performance and Kingsdown expansion.

Mattress Firm net sales $922M, same‑store sales grew slightly; Kingsdown products expanding to nearly 800 stores over the next six months.

### Margins / costs

Margins improved via pricing actions and synergies despite commodity inflation.

North America gross margin up 680 bps to 61.8%; international gross margin down 80 bps; $10M one‑time inflation headwind offset by pricing actions in H2.

### Capital allocation

Robust cash flow used to reduce debt, return $160M to shareholders, and fund $225M CapEx.

Operating cash flow $236M, free cash flow $182M, net debt reduced >$500M, dividends and buybacks $160M, CapEx $75M for store refresh, total $225M.

### Milestones

- **Mattress Firm store refresh program** [on_track]: Progress steady, targeted completion in 2027.
- **Brand wall program** [on_track]: Expected to wrap up in 2026.
- **Kingsdown product expansion** [on_track]: Presence expected in nearly 800 stores nationwide within six months.
- **Stearns & Foster product launch** [on_track]: Launch begins end Q3 2026, rolling through early 2027.
- **International acquisitions (Dreams, SOVA, SENG)** [delivered]: Acquisitions completed, enhancing vertical integration.
- **Leggett & Platt combination** [at_risk]: Regulatory approvals received, shareholder vote Aug 20, closing pending.
- **Dreams ERP implementation** [at_risk]: Implementation going well but created transitory challenges.
- **Commodity pricing actions** [delivered]: Modest pricing actions implemented after July 4 promo to offset input costs.

### Fears / risks

- **Macroeconomic uncertainty**: Consumer demand could be pressured by ongoing macroeconomic volatility.
- **Commodity cost inflation**: Higher input and freight costs created a $10M headwind, requiring pricing actions.
- **ERP implementation challenges**: Dreams' ERP rollout has created transitory challenges affecting operations.
- **Competitive pressure in UK**: Dreams faces a very tough UK market and intense promotional competition.
- **Integration risk Leggett & Platt**: Closing the Leggett & Platt combination depends on shareholder approval and regulatory steps.
- **Consumer financing costs**: Mattress Firm margins pressured by higher consumer financing costs.
- **E‑commerce growth limit**: Potential plateau in e‑commerce bedding sales may constrain top‑line growth.
- **Geopolitical uncertainty**: Middle East tensions could affect capital allocation decisions.

### Key quotes

> “We are pleased to deliver a record second quarter in adjusted earnings per share.”

> “We've gotten to more of a natural size of e-commerce bedding, difficult product to buy online, can't feel it, all that kind of stuff.” — Scott Thompson

> “We may never do another deal, or we may do some more deals in the future. There's nothing out there that is as large as Mattress Firm or as large as Leggett.”

> “Our second quarter results reflect the strength and resilience of our business model, the dedication of our teams, and the benefit of a disciplined long-term strategy.” — Scott Thompson

## Quarter one-liners

- **2026 Q2:** SomniGroup posted a record Q2 adjusted EPS of $0.58 on $1.8B sales, highlighted strong Mattress Firm performance, Kingsdown expansion, ongoing store refreshes, pricing actions offsetting inflation, and a near‑final Leggett & Platt deal.
- **2026 Q1:** Somnigroup Q1 2026: 12% sales growth to $1.8B, 20% adj EPS growth, reaffirmed FY26 guidance, leveraging Mattress Firm integration, pricing actions to offset commodity inflation, Leggett & Platt combination announced.','tone': {'mgmt': 0.7, 'mgmt_rationale': 'Management highlighted strong Q1 results 
- **2025 Q4:** SGI posted record Q4 sales and EBITDA, highlighted synergy gains from Mattress Firm, strong international growth, and new advertising, while noting a soft U.S. market and integration risks.
- **2025 Q3:** Somnigroup posted a record Q3 with 63% sales growth, strong synergies from the Mattress Firm acquisition and raised 2025 EPS guidance despite a flat U.S. bedding market and housing‑market headwinds.
- **2025 Q2:** SGI Q2: record sales $1.9B, adj EBITDA $291M; Mattress Firm integration ahead of plan with $40M EBITDA benefit in 2025; raised EPS guidance to $2.40-$2.70; Sealy launch momentum; international strong.','tone': {'mgmt': 0.7, 'mgmt_rationale': 'Management highlighted record results, smooth Mattress Fi
- **2025 Q1:** SGI Q1 2025: $1.6B sales, $0.49 adj EPS; outperformed weak US market; international growth; Sealy launch; tariff mitigation; Mattress Firm synergies; lowered 2025 EPS guidance to $2.30-$2.65 on weaker consumer confidence.','tone': {'mgmt': 0.2, 'mgmt_rationale': 'Management highlighted outperformanc
- **2024 Q4:** SGI completed Mattress Firm merger, guided 2025 EPS $2.60-$3.00 (10% growth), expects industry normalization H2 2025, targets $4.85 EPS by 2028 (20% CAGR) with $100M synergies.','tone': {'mgmt': 0.3, 'mgmt_rationale': 'Management highlights record 2024 margins, cash flow, deleveraging, and long-term
- **2024 Q3:** Tempur Sealy Q3: sales +2%, adj EBITDA +6%, margin 21.1% (10-qtr high); Int'l +12% sales, 200bps margin expansion; US Sealy Posturepedic launch H1 2025; Mattress Firm trial Nov 12; guidance narrowed to $2.45-2.55 adj EPS.','tone': {'mgmt': 0.3, 'mgmt_rationale': 'Management highlighted strong margin

## Theme arcs

- **Mattress Firm integration** (improving): Synergy benefits grew from early integration ahead of plan to record EBITDA contributions and multiple on‑track refresh milestones.
- **International expansion** (improving): Consistent sales growth, on‑track expansion milestones and 2026 acquisitions (Dreams, SOVA, SENG) signal accelerating global footprint.

## Guidance path

2024 Q3:vague → 2024 Q4:vague → 2025 Q1:vague → 2025 Q2:vague → 2025 Q3:raised → 2025 Q4:maintained → 2026 Q1:vague → 2026 Q2:maintained

---

Research context only. Not personalized investment advice.

API: `GET /bff/api/bigfive/earnings-intel/SGI`
